Mexico approves world’s first dengue vaccine


Mexico’s Federal Commission for the Protection against Sanitary Risks (Cofepris) has approved a vaccine against dengue fever – the first ever vaccine to be approved for this mosquito-borne disease.

The World Health Organization estimates that half of the world's population is at risk from dengue. Its symptoms include fever, joint pain and vomiting, which can become lethal.

Dengvaxia from Sanofi’s vaccines division, Sanofi Pasteur, protects against all four dengue virus serotypes and will be aimed at residents in endemic areas aged nine to 45. Although this does not cover very young children, who are often most vulnerable to the disease, Sanofi chief executive Olivier Brandicourt hailed the approval as ‘a historic milestone for our company, for the global public health community and, most importantly, for half the world’s population who live at risk of dengue’. 


Related Content

Silver lining for paper Ebola test

17 February 2015 Research

news image

Lateral flow test checks for Ebola, yellow fever and dengue in one go

10 years ago: Sanofi-Aventis takeover

30 May 2014 Flashback

news image

Aventis accepted a takeover bid from French rival Sanofi Synthélabo, creating the world's third largest pharma giant

Most Commented

Ethanol to butanol conversion shows sustainable potential

13 January 2016 Research

news image

Borrowed hydrogen chemistry drives reaction to obtain useful fuel from biomass

Injectable foam repairs bones

22 December 2015 Research

news image

Scientists say biomaterial could treat bone defects and diseases